SE466207B - 4'-desklorrebeccamycin och saett att framstaella detsamma - Google Patents

4'-desklorrebeccamycin och saett att framstaella detsamma

Info

Publication number
SE466207B
SE466207B SE8502135A SE8502135A SE466207B SE 466207 B SE466207 B SE 466207B SE 8502135 A SE8502135 A SE 8502135A SE 8502135 A SE8502135 A SE 8502135A SE 466207 B SE466207 B SE 466207B
Authority
SE
Sweden
Prior art keywords
strain
deschlororebeccamycin
inert
pharmaceutically acceptable
agar
Prior art date
Application number
SE8502135A
Other languages
English (en)
Swedish (sv)
Other versions
SE8502135L (sv
SE8502135D0 (sv
Inventor
J A Matson
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of SE8502135D0 publication Critical patent/SE8502135D0/xx
Publication of SE8502135L publication Critical patent/SE8502135L/
Publication of SE466207B publication Critical patent/SE466207B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SE8502135A 1984-09-04 1985-05-02 4'-desklorrebeccamycin och saett att framstaella detsamma SE466207B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/646,673 US4524145A (en) 1984-09-04 1984-09-04 4'-Deschlororebeccamycin pharmaceutical composition and method of use

Publications (3)

Publication Number Publication Date
SE8502135D0 SE8502135D0 (sv) 1985-05-02
SE8502135L SE8502135L (sv) 1986-03-05
SE466207B true SE466207B (sv) 1992-01-13

Family

ID=24594001

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8502135A SE466207B (sv) 1984-09-04 1985-05-02 4'-desklorrebeccamycin och saett att framstaella detsamma

Country Status (11)

Country Link
US (1) US4524145A (da)
JP (1) JPS61148192A (da)
CA (1) CA1249235A (da)
CY (1) CY1584A (da)
DK (1) DK160280C (da)
FR (1) FR2569702B1 (da)
GB (1) GB2164035B (da)
HK (1) HK22191A (da)
HU (1) HU193973B (da)
IT (1) IT1186723B (da)
SE (1) SE466207B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567143A (en) * 1984-09-04 1986-01-28 Bristol-Myers Company Process for preparing 4'-deschlororebeccamycin
US4743594A (en) * 1984-09-17 1988-05-10 Schering Corporation Antibiotic, antitumor compounds and their use
JPS62220196A (ja) * 1986-03-20 1987-09-28 Kyowa Hakko Kogyo Co Ltd 新規物質ｕｃｎ―０１
US4764510A (en) * 1986-04-11 1988-08-16 Eli Lilly And Company Antibiotic A42125 and process for its production
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
US5015578A (en) * 1989-03-23 1991-05-14 Bristol-Myers Squibb Company BMY-41950 antitumor antibiotic
IL97233A (en) * 1990-03-06 1995-03-30 Bristol Myers Squibb Co Analogs of rabamycin, their manufacture and pharmaceutical preparations containing them
US5158938A (en) * 1990-03-06 1992-10-27 Bristol-Myers Squibb Company Rebeccamycin
US5344823A (en) * 1990-03-06 1994-09-06 Bristol-Myers Squibb Company Antitumor antibiotic BMY-41219
EP0445736A1 (en) * 1990-03-06 1991-09-11 Bristol-Myers Squibb Company Rebeccamycin analog and pharmaceutical composition containing it
EP0630242B1 (en) * 1992-03-20 1999-01-20 The Wellcome Foundation Limited Further indole derivatives with antiviral activity
JP3603322B2 (ja) * 1992-12-14 2004-12-22 萬有製薬株式会社 インドロピロロカルバゾール誘導体の製造法
KR100313736B1 (ko) * 1993-06-04 2002-03-21 우에하라 아끼라 사람유래종양세포증식저해인자
WO1995034663A1 (fr) * 1994-06-13 1995-12-21 Banyu Pharmaceutical Co., Ltd. Gene codant la glycosyl-transferase et utilisation de ce gene
WO2004094645A1 (en) * 2003-04-22 2004-11-04 Lonza Ag Process for the recovery of staurosporine from a fermentation broth
MX2016016984A (es) 2014-07-07 2017-05-03 Honeywell Int Inc Material de interconexion termica con depurador ionico.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487925A (en) * 1983-01-28 1984-12-11 Bristol-Myers Company Rebeccamycin and process for its preparation

Also Published As

Publication number Publication date
GB2164035B (en) 1988-08-17
SE8502135L (sv) 1986-03-05
DK160280B (da) 1991-02-18
JPH0362715B2 (da) 1991-09-26
IT1186723B (it) 1987-12-16
GB8512334D0 (en) 1985-06-19
CA1249235A (en) 1989-01-24
HU193973B (en) 1987-12-28
CY1584A (en) 1992-04-03
HK22191A (en) 1991-04-04
DK160280C (da) 1991-07-22
FR2569702B1 (fr) 1988-10-28
IT8521002A0 (it) 1985-06-04
DK195585A (da) 1986-03-05
SE8502135D0 (sv) 1985-05-02
US4524145A (en) 1985-06-18
DK195585D0 (da) 1985-05-01
JPS61148192A (ja) 1986-07-05
GB2164035A (en) 1986-03-12
FR2569702A1 (fr) 1986-03-07
HUT39479A (en) 1986-09-29

Similar Documents

Publication Publication Date Title
SE466207B (sv) 4'-desklorrebeccamycin och saett att framstaella detsamma
US4552842A (en) Process for producing rebeccamycin
US4487925A (en) Rebeccamycin and process for its preparation
US5015578A (en) BMY-41950 antitumor antibiotic
US4518589A (en) BBM-2478 Antibiotic complex
US4567143A (en) Process for preparing 4'-deschlororebeccamycin
NO300812B1 (no) Fremgangsmåte for fremstilling av antitumorsubstans BE-13793C, samt biologisk ren kultur istand til å frembringe denne
US5073633A (en) BMY-41950 antitumor antibiotic
EP0182152B1 (en) Antitumor antibiotics (LL-E33288 Complex)
CA1230568A (en) Antitumor antibiotic compound
JPH02117676A (ja) Ｂｕ―３４２０ｔ抗腫瘍性抗生物質
US4336333A (en) Process for preparing tunicamycin
US4360595A (en) Fermentation process for producing anandimycin
US4543334A (en) Streptomyces capable of producing neutral macrolide antibacterial agents
US4626503A (en) Antitumor agents LL-D49194α1, LL-D49194β1, LL-D49194β2, LL-D49194β3, LL-D49194γ, LL-D49194δ, LL-D49194ε, LL-D49194ξ, LL-D49194η, LL-D49194ω1, LL-D49194ω2, and LL-D49194ω3
US4301248A (en) Fermentation process for making rachelmycin
US4572895A (en) Process for preparing an antibiotic complex by culturing actinomyces strain ATCC 39417
US4743594A (en) Antibiotic, antitumor compounds and their use
US4162938A (en) Antibiotic compound
JPH08512330A (ja) 海洋放線菌から単離した新規なチオデプシペプチド
NZ244774A (en) Protein-associated chromophore from actinomadura, pharmaceutical compositions and production
US5140101A (en) Antiviral antibiotic BU-4344V
EP1324980B1 (en) Citrullimycines, a process for their production and their use as pharmaceuticals
US4450237A (en) Streptomyces albus subspecies indicus
DK159320B (da) 19-epi-dianemycin og salte deraf, fremgangsmaade til fremstilling af 19-epi-dianemycin og mikroorganismekultur til anvendelse ved fremgangsmaaden samt farmaceutisk praeparat indeholdende 19-epi-dianemycin

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8502135-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8502135-0

Format of ref document f/p: F